Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth is swimming in cash, but does this make the largest cannabis stock in the world worth buying?

Is Pot Stock Canopy Growth a Buy in 2020?

2019 was difficult CGC stock. And, despite some possible long-term catalysts, 2020 could end up being just as subdued

New Year Will Likely Be Subdued For Canopy Growth Stock

Calendar 2019 was the year that CGC stock lost its "mojo", and 2020 will be the year that the stock gets it back.
The post Why Canopy Growth Stock Will Stage a Huge Rebound in 2020 appeared first on InvestorPlace.

Why Canopy Growth Stock Will Stage a Huge Rebound in 2020

Amgen

Merck

Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.

3 of the Best Healthcare Stocks to Buy in 2020

Canopy Growth Is Best Of Breed In Cannabis: How To Buy It With Lower Risk

Aurora Cannabis

MedMen Enterprises Inc.

The grass will not be greener with these cannabis stocks.

3 Marijuana Stocks to Avoid Like the Plague in 2020

Bristol-Myers

Cronos Group

Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.

Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth

It's going to be a whole lot more difficult to impress cannabis investors.

Here's Why 2020 Is the Big Test for Canadian Cannabis Companies

Aphria

SNDL Inc.

Tilray Brands

As a dismal 2019 comes to an end, investors appear to be looking to a brighter 2020.

Why Aurora Cannabis, Canopy Growth, and Other Top Canadian Marijuana Stocks Soared Today

Bank of America

Trulieve Cannabis Corp.

This is why the marijuana sector is not suitable for risk-averse investors.

1 Reason Cannabis Stocks Are Still Very Risky Buys

Canopy Growth has been hammered in 2019, along with the the rest of the cannabis space. Is a rebound ready to go?

Is Canopy Growth a Worthy Investment in 2020?

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

New Age Beverages

Constellation Brands

The political winds could shift regarding U.S. legalization.

1 Reason Marijuana Stocks Could Bounce Back in 2020

Canopy Growth stock outlook darkens with more losses. Canopy Growth reported lower revenue and further losses for its September quarter with profitability nowhere on the horizon.

It’s Getting Hard to See a Road to Profitability for CGC Stock

Amplify Seymour Cannabis ETF

Global X Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

2020 Cannabis Foresight + Year-End Rap With Javier Hasse (Podcast)

Being a cannabis stock pessimist was a profitable venture this year.

Short Sellers Made $791 Million in 2019 by Betting Against These 4 Pot Stocks

The cannabis industry suffered horribly in 2019 and Aurora Cannabis’ controversial executive departure creates a trust issue for Canopy Growth and other major players. 
The post Can Canopy Growth Rise Above the Cannabis Industry’s Reputation?

Can Canopy Growth Rise Above the Cannabis Industry’s Reputation?

CannTrust Holdings

Innovative Industrial Properties

Here's what the "buzz" will be about regarding marijuana and pot stocks in the upcoming year.

5 Trends That Will Dominate the Cannabis Landscape in 2020

HEXO Corp

Major pot producers and their beer partners have a full lineup of CBD drinks poised to hit store shelves.

Canopy, HEXO, and Tilray Have Marijuana Drinks Ready to Roll in Canada

In the latest trading session, Canopy Growth Corporation (CGC) closed at $19.20, marking a -0.1% move from the previous day.

Canopy Growth Corporation (CGC) Stock Moves -0.1%: What You Should Know

Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks.

U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020

Boeing

Uber

In spite of current hurdles, these three stocks have tremendous potential beyond their problems and you should hold them into the next decade.

3 Stocks to Buy and Own for the Next Decade

HD Supply Hlds

Scotts Miracle-Gro

Three mid-tier stocks that look positioned to reward investors in 2020.

3  Top Mid-Cap Stocks to Buy Right Now

Collectively, investors lost almost $10 billion on these pot stocks since the year began.

3 Marijuana Stocks That Cost Investors Billions in 2019

Yet, today's price may not be your best entry point. Wait for the shorts to clear out.

Canopy Growth Could Surprise in 2020, but Don’t Rush In

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Yield on Cannabis Stocks

News for Canopy Growth Stock (CGC)